The main active ingredient in the medication is Sevelamer Carbonate. It is a phosphate binder. This component is useful to prevent hypocalcemia caused by elevated phosphorus. It is indicated to control phosphorus levels in people with chronic kidney disease who are on dialysis. It also decreases serum phosphate concentrations. It does this without changing calcium, aluminum, or bicarbonate concentrations.
This mentioned medication is a phosphate binder used to prevent hypocalcemia i.e. low levels of calcium in the body that occurred by elevated phosphorus. Renagel controls phosphorus levels in people with chronic kidney disorders who are on dialysis. It is indicated to lower high blood phosphorus levels in people who are on dialysis due to severe kidney disease. The process of dialysis removes some phosphate from the blood. It is difficult to remove enough to keep phosphate levels balanced. Decreasing blood phosphate levels can help keep bones strong, and prevent unsafe buildup of minerals in the body. It also decreases the risk of heart disease and strokes that can be a consequence of high phosphate levels. It succumbs to phosphate from the diet and passes it out of the body.
- Stomach Pain
- Loss Of Appetite
- Upset Stomach
- Tired Feeling
- Joint Pain
This effective medicine is composed of the active ingredient sevelamer carbonate which is a non-absorbed phosphate binder. It is a crosslinked polymer, free of metal and calcium. It acts by binding phosphate in the gastrointestinal tract and decreasing absorption, Renagel medication reduces the phosphate concentration in the serum.
This phosphate binder drug is made available in a dosage as given below:
- 800 mg: It should be taken orally 3 times a day with meals as mentioned in the prescription by the doctor
Avoid consuming any other drugs within 1 hour before or 3 hours after taking this medicine. Pregnant or breastfeeding women should consult a doctor.